Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trialShukui Qin, Yabing Guo, Minshan Chen et al.|The Lancet|2023Cited by 514
Combined PD-L1/TGFβ blockade allows expansion and differentiation of stem cell-like CD8 T cells in immune excluded tumorsAlessandra Castiglioni, Sören Müller, Justin A. Shyer et al.|Nature Communications|2023Cited by 96
<scp>PAK1</scp> mediates pancreatic cancer cell migration and resistance to <scp>MET</scp> inhibitionWei Zhou, Klaus P. Hoeflich, Adrian M. Jubb et al.|The Journal of Pathology|2014Cited by 56